文献速递肿瘤 PET/CT

68Ga-FAPI-04 PET/CT 在非小细胞肺癌中的应用:准确评估淋巴结转移并与成纤维细胞活化蛋白表达相关

68Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression.
PubMed 文献 · J Nucl Med · 2024-04-01

该回顾性研究纳入136例疑似或活检确诊的非小细胞肺癌(NSCLC)患者,评估68Ga-FAPI-04 PET/CT对原发灶及淋巴结转移的诊断效能,并分析肿瘤摄取与成纤维细胞活化蛋白(FAP)表达的相关性。最终91例NSCLC患者纳入分析,淋巴结转移站分析灵敏度72.00%、特异度93.10%、准确率89.36%,肿瘤SUVmax、SUVmean、FTV、TLF均与FAP表达正相关。

要点

  • 68Ga-FAPI-04 PET/CT诊断原发灶灵敏度96.70%(88/91),阳性预测值100%(88/88)。
  • 淋巴结转移站分析灵敏度72.00%(18/25)、特异度93.10%(108/116)、准确率89.36%(126/141)。
  • 肿瘤SUVmax、SUVmean、FTV、TLF与FAP表达正相关(r=0.470、0.477、0.582、0.608,均P≤0.001)。

核心结论

  • 68Ga-FAPI-04 PET/CT对NSCLC淋巴结转移检测具有优良诊断效能,且68Ga-FAPI-04摄取与FAP表达密切相关。

研究设计与样本

  • 回顾性纳入136例疑似或活检确诊的NSCLC患者,均因初始分期行68Ga-FAPI-04 PET/CT检查。
  • 以最终组织病理学或典型影像学特征为参考标准,评估68Ga-FAPI-04对NSCLC的诊断效能。
  • 测量并计算SUVmax、SUVmean、68Ga-FAPI高摄取肿瘤体积(FTV)和总病灶FAP表达(TLF),并对组织标本行FAP免疫染色。
  • 采用Spearman相关系数评估68Ga-FAPI-04摄取与FAP表达的相关性。
  • 最终91例NSCLC患者(中位年龄65岁,四分位距58-70岁;男性69例)纳入分析。

主要发现

  • 病灶分析中,68Ga-FAPI-04 PET/CT检测原发肿瘤的灵敏度为96.70%(88/91),阳性预测值为100%(88/88)。
  • 站分析中,检测淋巴结转移的灵敏度为72.00%(18/25),特异度为93.10%(108/116),准确率为89.36%(126/141)。
  • 肿瘤68Ga-FAPI-04摄取(SUVmax、SUVmean、FTV、TLF)与FAP表达呈正相关(r分别为0.470、0.477、0.582、0.608,均P≤0.001)。
  • 31例手术标本中,体积参数FTV和TLF与FAP表达强相关(r分别为0.700和0.770,均P<0.001)。

关键数值与推荐

  • 原发肿瘤病灶分析:灵敏度96.70%(88/91),阳性预测值100%(88/88)。
  • 淋巴结转移站分析:灵敏度72.00%(18/25),特异度93.10%(108/116),准确率89.36%(126/141)。
  • SUVmax与FAP表达相关r=0.470(P≤0.001);SUVmean与FAP表达相关r=0.477(P≤0.001)。
  • FTV与FAP表达相关r=0.582(P≤0.001);TLF与FAP表达相关r=0.608(P≤0.001)。
  • 31例手术标本中FTV与FAP表达相关r=0.700(P<0.001),TLF与FAP表达相关r=0.770(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fibroblast activation protein (FAP) is a promising diagnostic and therapeutic target in various solid tumors. This study aimed to assess the diagnostic efficiency of 68Ga-labeled FAP inhibitor (FAPI)-04 PET/CT for detecting lymph node metastasis in non-small cell lung cancer (NSCLC) and to investigate the correlation between tumor 68Ga-FAPI-04 uptake and FAP expression. Methods: We retrospectively enrolled 136 participants with suspected or biopsy-confirmed NSCLC who underwent 68Ga-FAPI-04 PET/CT for initial staging. The diagnostic performance of 68Ga-FAPI-04 for the detection of NSCLC was evaluated. The final histopathology or typical imaging features were used as the reference standard. The SUVmax and SUVmean, 68Ga-FAPI-avid tumor volume (FTV), and total lesion FAP expression (TLF) were measured and calculated. FAP immunostaining of tissue specimens was performed. The correlation between 68Ga-FAPI-04 uptake and FAP expression was assessed using the Spearman correlation coefficient. Results: Ninety-one participants (median age, 65 y [interquartile range, 58-70 y]; 69 men) with NSCLC were finally analyzed. In lesion-based analysis, the diagnostic sensitivity and positive predictive value of 68Ga-FAPI-04 PET/CT for detection of the primary tumor were 96.70% (88/91) and 100% (88/88), respectively. In station-based analysis, the diagnostic sensitivity, specificity, and accuracy for the detection of lymph node metastasis were 72.00% (18/25), 93.10% (108/116), and 89.36% (126/141), respectively. Tumor 68Ga-FAPI-04 uptake (SUVmax, SUVmean, FTV, and TLF) correlated positively with FAP expression (r = 0.470, 0.477, 0.582, and 0.608, respectively; all P ≤ 0.001). The volume parameters FTV and TLF correlated strongly with FAP expression in 31 surgical specimens (r = 0.700 and 0.770, respectively; both P < 0.001). Conclusion: 68Ga-FAPI-04 PET/CT had excellent diagnostic efficiency for detecting lymph node metastasis, and 68Ga-FAPI-04 uptake showed a close association with FAP expression in participants with NSCLC.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Li C, Chen Q, Tian Y, et al. 68Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression. J Nucl Med. 2024. PMID: 38453362. doi:10.2967/jnumed.123.266806

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。